Biochip Technology to Revolutionise the Pharmaceutical Industry

17-May-2004

Advancements in biotechnology have culminated in its integration with semiconductor technologies such as micro-electromechanical systems, resulting in the evolution of biochips. Biochips provide pharma companies with sophisticated tools for speedy development of drugs and accurate diagnosis and understanding of biological mechanisms. New analysis from Technical Insights (http://technicalinsights.frost.com) states: "DNA and protein biochips streamline drug development and significantly lower average drug screening costs from $2 to $0.0001. However, in order for biochip manufacturing to be successful, maintaining the precision involved in making the silicon chips and handling delicate DNA molecules is essential." Biochips also simplify the decoding of genes in order to completely understand their role in health and disease. Other practical applications include handheld devices for testing microbes in food and DNA fingerprinting. Additionally, bioterrorism and biowarfare threats are driving demand for biochips, which are likely to be critical to detect biological and chemical warfare agents. With the transition of the medical lab-on-chip (LOC) from a concept to a reality, the focus has been on developing high-density and smaller-sized biochips where less than 300 wafers can accommodate the entire human genome. As opposed to conventional laboratory analysis, LOCs eliminate the need for trained personnel and expensive equipment to provide significant time and cost efficiencies. Recent innovations in Europe have given rise to the 'lab-on-a-pill' initiative that is likely to change the future of diagnostic procedures. It relies on a biosensor and system-on-chip technology that examines bodily fluids for crucial data such as temperature, dissolved oxygen and pH levels. Also, its ease of use is likely to stimulate Replacement of invasive endoscopic procedures and aid in early detection of colon cancer. The biosensor chip technology also provides quick and easy access to critical information regarding DNA damage from cancer-producing compounds, taking researchers a step closer in the fight against cancer. A laser-based, high-resolution and low-temperature fluorescence method provides a direct fingerprint of the molecule, unlike conventional biosensing methods. Though plastic, silicon and glass protein biochips capture molecules, the proteins bind only to that portion of the chip where they locate a natural interaction partner. Researchers in Europe are now developing a new protein microchip based on silica-based nanoparticles that are not as selective and capture numerous proteins. This is likely to aid in the early detection of illnesses and provide greater sensitivity in molecular biology research, drug screening and diagnostics. The rapid evolution of glycomics as a natural extension of proteomics has provided a better understanding of glycoproteins and Glycosylation, and their role in the protein function. This enriches the biopharmaceutical industry with novel protein-based biodrugs. The progress of glycomics in the biopharmaceutical industry is evident from the existence of approximately half a dozen drugs in which manipulation of carbohydrates and proteins provides advanced drug properties. For example, Epogen - the glycotherapeutic drug - contains two additional carbohydrate groups that can extend circulatory half-life and magnify efficiencies. "Glycoprotein therapeutics is the fastest growing segment in the biopharmaceuticals industry where raising the production capacity at least by four times more than the existing capacity is a significant challenge," notes Technical Insights. "Alternate manufacturing media such as transgenic plants and animals, besides the mammalian and microbial/fungal cell culture systems, is expected to play an important role in tackling this issue". Fungal cell lines provide considerable time and cost benefits over mammalian cell lines. For instance, the latter is not only a lengthy process, but is also likely to alter the properties of the final therapeutic glycoprotein. Conversely, fungal cell lines such as engineered yeast expression systems facilitate production of humanly glycosylated protein, provide faster fermentation and generate higher product yield. Reverse genomics that identifies therapeutic proteins through a deconstructive approach is another relatively new concept cashing in on the success of biotechnology. It hinges upon chemical genomics and proteomics to link potentially therapeutic compounds to proteins, define the role of these proteins in cellular pathways and ultimately to detect the mode-of-action of drug candidates. Nanobiotechnology is also creating a new revolution in the pharmaceuticals industry, which has always been keen on developing better drug delivery systems. Small size, unique physical structures and electronic properties facilitate novel site-specific and controlled release of drugs. Additionally, minute nanoparticles such as quantum dots may serve as imaging agents, revolutionising conventional diagnostic imaging. Biotechnology Industry Impact Service, part of the Biotech Vertical Subscription Service, provides a comprehensive analysis of recent technological advances in biotechnology. It provides key technical challenges, drivers, and cutting-edge developments influencing market growth. The study also evaluates emerging applications, which enable participants to ascertain future opportunities. Executive summaries and interviews are available to the press. If you are interested in an analysis overview which provide manufacturers, end-users and other industry participants an overview, summary, challenges and latest coverage of the Biotechnology Industry Impact Service - then use the Info Request button below.

https://www.bionity.com/en/news/37677/biochip-technology-to-revolutionise-the-pharmaceutical-industry.html

Topics

proteins biochips cell lines biotechnology temperature silicon proteomics nanoparticles genomics drug screening yeasts therapeutic proteins Replacement quantum dots oxygen molecular biology microbes human genome Glycosylation glass genes food fermentation Epogen drug development drug delivery DNA damage diagnostics density colon cancer cell cultures carbohydrates biopharmaceuticals containers

Show all

Organizations

Frost & Sullivan

Fighting cancer: latest developments and advances

Discover cancer news

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products

4 whitepaper

10+ brochures

View topic world

Topic world Diagnostics

10+ products

4 whitepaper

10+ brochures

View topic world

Topic world biopharmaceutical manufacturing

Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.

20+ products

15+ brochures

View topic world

Topic world biopharmaceutical manufacturing

20+ products

15+ brochures

View topic world

More from the department business & finance Subscribe to newsletter

Get the life science industry in your inbox

Biochip Technology to Revolutionise the Pharmaceutical Industry

Playing it safe

Other news from the department business & finance

“Restore trust and get Bayer on track for better performance”

CARBIOS celebrates the groundbreaking of its PET biorecycling plant

SeaBeLife awarded over €1.5 million in i-Nov innovation competition

Merck Invests More Than € 300 Million in New Life Science Research Center in Germany

Discover the world of biopharmaceutical manufacturing

Bruker to acquire the NanoString business in an asset deal

AI for medical documentation is a rapidly growing future market

Start-up aims to open the door to an entirely new approach to immunotherapy

Labguru joins Titian Software in Battery Ventures Life-Science Platform

Breakthrough technology to rapidly identify unknown molecules at scale

CureVac and MD Anderson enter strategic collaboration to develop novel cancer vaccines

Cyber Valley grants 500K to CELL’n’ROLL via 2023 Innovation Fellowship Program

analytica 2024 confirms its position as the world’s leading trade fair for the laboratory sector

Game changer in fighting cancer: BioCopy expands corporate portfolio with acquisition of start-up Perspix Biotech

Coral researchers awarded EXIST start-up funding

BASSETTI GROUP acquires the German software provider MAQSIMA

Start-up aims to harness the natural powers of cancer survivors to cure this life-threatening disease

Million Euro Boost for Neuro Start-up to Address Mental Health Disorders with Flickering Light

Highly effective disinfectant made from food production waste

Eppendorf Renews Founding Sponsorship with LabCentral

Get the life science industry in your inbox

Most read news

Common household chemicals pose new threat to brain health

The mother's protein intake affects the newborn's face

Unfavourable carbohydrates early in the morning - a potential problem for "owls"

Sustainable plastics from agricultural waste

Memory self-test via smartphone can identify early signs of Alzheimer’s disease

Microbe of the Year 2023: Bacillus subtilis – for health and technology

Innovative treatment helmet from a Basel spin-off promises advances in the treatment of Alzheimer’s

Gut microbiota and antibiotics: Missing puzzle piece discovered

Music and Genomes: Beethoven’s Genes Put to the Test

With the Flick of a Switch: Shaping Cells with Light

Highly effective disinfectant made from food production waste

How your eye color affects your health

More news from our other portals

Battery material for the sodium-ion revolution

Sweet success: researchers crack sugarcane’s complex genetic code

Novel UV Broadband Spectrometer Revolutionises Air Pollutant Analysis

Nadja Håkansson appointed Chief Executive Officer of thyssenkrupp Uhde

Milk on ice: Antarctic time capsule of whole milk powder sheds light on the enduring qualities—and evolution—of dairy products past and present

Advanced imaging techniques on a semiconductor material reveal ‘surprising’ hidden activity

Research team develops sodium battery capable of rapid charging in just a few seconds

Asparagus enjoyment - that's what counts

Particle surface properties and their understanding - a trend also among young scientists

More efficient, lighter, more sustainable: researchers develop next-generation batteries

Green light from the antitrust authorities

Tests confirm quality of purified graphite from used lithium-ion batteries

Smart formulation in food technology

Highest power efficiency achieved in flexible solar cells using new fabrication technique

Gustavo Gusto calls the "Ghostbusters"

Atomic-scale semiconductor process technology and clean hydrogen technology join hands

AI predicts the taste and quality of beer

New reactor could save millions when making ingredients for plastics and rubber from natural gas

Do sweeteners increase your appetite?

New materials discovered for safe, high-performance solid-state lithium-ion batteries

Take it from the rats: A junk food diet can cause long-term damage to adolescent brains

Novel hydrogel removes microplastics from water

Easter egg without cruelty to animals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Diagnostics

Topic world Diagnostics

Topic world biopharmaceutical manufacturing

Topic world biopharmaceutical manufacturing